Stay updated with breaking news from Practice Patterns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patientsAD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRFirst approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patientsFirst launches in Europe expe...
Background and purpose: Radiotherapy utilisation rates considerably vary across different countries and service providers, highlighting the need to establish reliable benchmarks against which utilisation rates can be assessed. Here, optimal utilisation rates of Stereotactic Ablative Body Radiotherapy (SABR) for lung cancer are estimated and compared against actual utilisation rates to identify potential shortfalls in service provision. Materials and Methods: An evidence-based optimal utilisation model was constructed after reviewing practice guidelines and identifying indications for lung SABR...
Press release content from Business Wire. The AP news staff was not involved in its creation.
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Committee for Medicinal Products for Human Use recommends approval of Kapruvia® as first therapy in Europe for the treatment of chronic kidney... | February 28, 2022
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Committee for Medicinal Products for Human Use (CHMP) recommends approval of Kapruvia(difelikefalin) as first therapy in Europe for the treatment of